CytoDyn, Inc. filed a Form 8-K on November 20, 2026, disclosing the final certified voting results from its 2026 Annual Meeting of Stockholders held the same day.

Key Highlights

  • All five director nominees elected: Tanya Durkee Urbach, Lishomwa C. Ndhlovu M.D. Ph.D., Karen J. Brunke Ph.D., Ryan M. Dunlap, and Stephen M. Simes each received stockholder approval to serve until the 2027 annual meeting.
  • Highest vote for a director: Ryan M. Dunlap received 432,734,124 votes in favor, with 30,260,891 withheld and 309,846,575 broker non-votes.
  • Lowest vote for a director: Tanya Durkee Urbach received 414,695,411 votes in favor, with 48,299,604 withheld and 309,846,575 broker non-votes.
  • Auditor selection approved: The advisory vote on CBIZ CPAs P.C. as independent registered public accounting firm for the fiscal year ending May 31, 2027, passed with 761,073,421 votes for, 5,773,455 against, and 5,994,714 abstentions.
  • Executive compensation approved: The advisory vote on named executive officer compensation passed with 380,137,658 votes for, 72,139,425 against, 10,717,930 abstentions, and 309,846,577 broker non-votes.
  • Inspector of Election certified results on November 20, 2026, the same date as the meeting.

CytoDyn 2026 Annual Meeting Voting Results in Detail

CytoDyn, Inc., incorporated in Delaware and headquartered at 1111 Main Street, Suite 660, Vancouver, Washington 98660, held its 2026 Annual Meeting of Stockholders on November 20, 2026. The Inspector of Election issued its final certified report on the same date. The company's securities are not registered on a national exchange; the filing lists no trading symbol under Section 12(b) of the Act.

According to the filing, all five director nominees were elected to serve until the 2027 annual meeting of stockholders "and until their successors are duly elected and qualified or until their earlier death, resignation, or removal." Lishomwa C. Ndhlovu M.D. Ph.D. received 432,454,527 votes in favor; Karen J. Brunke Ph.D. received 430,245,377; and Stephen M. Simes received 432,202,700. Each nominee also faced 309,846,575 broker non-votes, as reported in the filing.

On the advisory vote to select CBIZ CPAs P.C. as the company's independent registered public accounting firm for the fiscal year ending May 31, 2027, the filing reports that stockholders voted 761,073,421 in favor, 5,773,455 against, and 5,994,714 abstentions. The advisory vote on the compensation of named executive officers resulted in 380,137,658 votes for, 72,139,425 against, 10,717,930 abstentions, and 309,846,577 broker non-votes, according to the filing. The report was signed by Tyler Blok, Chief Legal Officer and Corporate Secretary, on November 20, 2026.

What Was Disclosed

CytoDyn, Inc. disclosed the certified final voting results from its November 20, 2026 Annual Meeting, covering the election of five directors, an advisory vote on its independent auditor, and an advisory vote on named executive officer compensation.